Publications

Patents:

  1. Katharigatta N Venugopala, Pran Kishore Deb, Raghu Prasad Mailavaram, Nizar A Al-Shar’i, Swastika Ganguly, Bapi Gorain, Lim Tse Mun, Jamie Kow Kean Hing. “Thieno [2, 3-d] pyrimidines as COX-2 inhibitors”. US Patent 11,932,656, 2024.
  2. Katharigatta N Venugopala, Pran Kishore Deb, Rashmi Venugopala, Nizar A Al-Shar’i, Mohamed A Morsy, Bandar E Aldhubiab. “4-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1, 2, 4-triazole-3-thiol derivatives as antifungal agents”. US Patent 11,926,602, 2024.

Research articles:

  1. Katharigatta N. Venugopala, Wafa Hourani, Pran Kishore Deb, Maysa Alhawamdeh, Nizar Al-Shar’i, Pobitra Borah, Lina A. Dahabiyeh, Abdulmuttaleb Jaber, P Nefisath, S Shashiprabha, Jagadeesh Prasad Dasappa. “Anticancer and cyclooxygenase inhibitory activity of benzylidene derivatives of fenobam and its thio analogues”. Submitted.
  2. Ogochukwu Ngozi Nwaefulu, Nizar A. Al-Shar’i, Lam Kok Wai, Mohammad Kaisarul Islam, Lim Chee Woei, Josephine Omonkhelin Owolabi, Sreenivasa Rao Sagineedu, and Johnson Stanslas. “Isolation and structural elucidation of compounds from Synclisia scabrida (Miers) ex Oliv and their in vitro cytotoxicity and in-silico studies”. Submitted.
  3. Ruba Anwar Salou, Pran Kishore Deb, Wafa Hourani, Nizar Al-Shar’i, Amal Al Aboudi, Katharigatta N. Venugopala, Lina A. Dahabiyeh, Ipsha Shruti, Dee0pak Chopra. “Synthesis, X-ray Crystallography, and Computational Evaluation of 2,4-disubstituted-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine Derivatives as Cyclooxygenase 2 (COX 2) Inhibitors and Anticancer Agents”. Under review. 
  4. Manar Al-Sarhan, Lara I. Fakhouri, Nizar A. Al‑Shar’i, and Qosay Albalas. “Lead Optimization of TOPK Inhibitors using Complementary Computational and Synthetic Approaches.” Pharmaceutical Sciences, (2024), https://doi.org/10.34172/PS.2024.20. [Impact factor 1.4].
  5. Buthina Al-Oudat, Bushra Abu Al fool, Suaad A. Audat, Nizar A. Al-Shar’i, Qosay A. Al-Balas, Aref Zayed, Amanda Bryant-Friedrich. “Structural optimization and biological evaluation of quinoline/naphthalene-based glyoxalase-I inhibitors as anti-cancer candidates”. Medicinal Chemistry Research, (2024), https://doi.org/10.1007/s00044-024-03289-x. [Impact factor 2.6].
  6. Banan Alomari, Lara Fakhouri, Nizar Al-Shar’i, Qosay Albalas. “Design, Synthesis and Biological Evaluation of Potent Thiazolidinedione Salicylic Acid Inhibitors Against Glyoxalase-I as Potential Anticancer Agents”. Medicinal Chemistry Research, (2024), https://doi.org/10.1007/s00044-024-03247-7. [Impact factor 2.6].
  7. Katharigatta N. Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, Nizar A. Al-Shar’i, Melendhran Pillay, Deepak Chopra, Pobitra Borah, Rasoul Tamhaev, Lionel Mourey, Christian Lherbet, Bandar E. Aldhubiab, Christophe Tratrat, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Raghu Prasad Mailavaram, Rashmi Venugopala, Viresh Mohanlall, Mohamed A. Morsy. “Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies”. International Journal of Biological Macromolecules, (2024). https://doi.org/10.1016/j.ijbiomac.2024.133285. [Impact factor 8.2].
  8. Nizar Al-Shar’i, “The design of TOPK inhibitors using similarity search, molecular docking, and MD simulations”. Journal of Biomolecular Structure and Dynamics, 1-12, (2024).  https://doi.org/10.1080/07391102.2024.2319107. [Impact factor 6.25].
  9. Shende, Sondarya Uttam, Nizar A. Al-Shar’i, Surbhi Mahender Saini, Viresh Mohanlall, Raquel M. Gleiser, Pran Kishore Deb, Mohamed A. Morsy, Katharigatta N. Venugopala, and Sandeep Chandrashekharappa. “Synthesis, characterization and larvicidal studies of ethyl 3-benzoyl-7-(piperidin-1-yl)indolizine-1-carboxylate analogues against Anopheles arabiensis and cheminformatics approaches”. Journal of Biomolecular Structure and Dynamics.1-13. (2024). https://doi.org/10.1080/07391102.2024.2311881. [Impact factor 6.25].
  10. Ramasamy Duraia, Nizar A. Al-Shar’i, Sandeep Chandrashekharappa, Pran Kishore Deb, Osama I. Alwassil, Raquel M. Gleiser, Christophe Tratrat, Mohamed A. Morsy, Madhusudana Reddy Muthukurpalya Bhojegowd, Dhakshanamurthy Thirumalai, Viresh Mohanlall, Mohamad Fawzi Mahomoodallyk, Mahmoud Kandeel, Wael El-Deeb, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Rashmi Venugopala, Hassan H. Abdallah, Michelyne Haroun, Katharigatta N. Venugopalag and Yasmine F. Ibrahim. “Synthesis, biological evaluation and computational investigation of ethyl 2,4,6-trisubstituted-1,4-dihydropyrimidine-5-carboxylates as potential larvicidal agents against Anopheles arabiensis”. Journal of Biomolecular Structure and Dynamics, (2023), https://doi.org/10.1080/07391102.2023.2217929.  [Impact factor 5.235].
  11. Ogochukwu Ngozi Nwaefulu, Nizar A. Al-Shar’i, Josephine Omonkhelin Owolabi, Sreenivasa Rao Sagineedu, Lim Chee Woei, Lam Kok Wai, Mohammad Kaisarul Islam, Johnson Stanslas. “The Impact of Cycleanine in Cancer Research: A Computational Study“. Journal of Molecular Modelling (2022), volume 340 (28). https://doi.org/10.1007/s00894-022-05326-1. [Impact factor 2.172].
  12. Hadeia Mashaqbeh, Rana Obaidat, Nizar Al-Shar’i. “Evaluation of EDTA dianhydride versus Diphenyl carbonate Nanosponges for Curcumin”. AAPS PharmSciTech (2022), volume 23, Article number: 229. https://doi.org/10.1208/s12249-022-02372-z. [Impact factor 4.026].
  13. Hadeia Mashaqbeh, Rana Obaidat, Nizar Al-Shar’i, Tamam El-Elimat, and Soraya Alnabulsi. “Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin: in vitro and in silico studies“. Research in Pharmaceutical Sciences. (2022),volume 17 (4), p: 334-349. https://doi.org/10.4103/1735-5362.350235. [Impact factor 3.133].
  14. Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Wafa Hourani, Pran Kishore Deb, Melendhran Pillay, Bashaer Abu-Irmaileh, Yasser Bustanji, Sandeep Chandrashekharappa, Christophe Tratrat, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Pottathil Shinu, Michelyne Haroun, Mahmoud Kandeel, Abdulmalek Ahmed Balgoname, Rashmi Venugopala, Mohamed A. Morsy. “Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives”. Antibiotics. (2022), volume 11 (7), p: 831. https://doi.org/10.3390/antibiotics11070831. [Impact factor 4.639].
  15. Suaad Abdallah Audat, Nizar A. Al-Shar’i, Buthina Abdallah Al-Oudat, Soraya Alnabulsi. “Design, synthesis, and biological evaluation of SMYD3 inhibitors possessing N-thiazole benzenesulfonamide moiety as potential anti-cancer agents”. Journal of Saudi Chemical Society. (2022), volume 26 (3), article number 101482, https://doi.org/10.1016/j.jscs.2022.101482. [Impact factor 3.932].
  16. Venugopala, Katharigatta N., Pottathil Shinu, Christophe Tratrat, Pran K. Deb, Raquel M. Gleiser, Sandeep Chandrashekharappa, Deepak Chopra, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Fawzi M. Mahomoodally, Michelyne Haroun, Mahmoud Kandeel, Syed M.B. Asdaq, Viresh Mohanlall, Nizar A. Al-Shar’i, and Mohamed A. Morsy. “1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector Anopheles arabiensis and In Silico Molecular Docking Study”. Molecules. (2022), volume 27 (9), p: 2676; https://doi.org/10.3390/molecules27092676. [Impact factor 4.412].
  17. Rana Obaidat, Batool Al-Ghzawi, Bashar Al-Taani, Nizar Al-Shar’i. “Co-crystallization of Amoxicillin trihydrate and Potassium clavulanate Provides a Promising Approach for Preparation of Sustained-release Microspheres”. AAPS PharmSciTech. (2022), volume 23, article number 131. https://doi.org/10.1208/s12249-022-02273-1. [Impact factor 3.246].
  18. Buthina A. Al-Oudat, Nizar A. Al-Shar’i, Amanda Bryant-Friedrich, Qosay A. Al‑Balas, Suaad A. Audat, Mel F. Bedi, Ali H. Hamzah, Ramez W. Hallak, Mohammad Ali Alqudah. “Lead Optimization and Biological Evaluation of Diazenylbenzenesulfonamides Inhibitors Against Glyoxalase-I Enzyme as Potential Anticancer Agents”. Bioorganic Chemistry. (2022), Volume 120, article number 105657; https://doi.org/10.1016/j.bioorg.2022.105657.  [Impact factor 5.275].
  19. Lara Fakhouri, Nizar A. Al-Shar’i. “The Design of TOPK Inhibitors Using Structure-Based Pharmacophore Modelling and Molecular Docking Based on an MD-Refined Homology Model”. Molecular Diversity.(2022), https://doi.org/10.1007/s11030-021-10361-w. [Impact factor 2.943].
  20. Hadeia Mashaqbeh, Rana Obaidat and Nizar Al-Shar’i. “Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation”. Polymers. (2021), volume 13 (23), pp 4073; https://doi.org/10.3390/polym13234073. [Impact factor 4.329].
  21. Katharigatta N. Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, Christophe Tratrat, Melendhran Pillay, Deepak Chopra, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Wafa Hourani, Pobitra Borah, Rahul D. Nagdeve, Susanta K. Nayak, Basavaraj Padmashali, Mohamed A. Morsy, Bandar E. Aldhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Michelyne Haroun, Sheena Shashikanth, Viresh Mohanlall. “Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme”. Journal of Enzyme Inhibition and Medicinal Chemistry. (2021), volume 36 (1), pp 1471-1486, https://doi.org/10.1080/14756366.2021.1919889.[Impact factor 4.673].
  22. Pran Kishore Deb, Nizar A. Al-Shar’i, Katharigatta N. Venugopala, Melendhran Pillay, Pobitra Borah. “In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis”. Journal of Enzyme Inhibition and Medicinal Chemistry. (2021), volume 36 (1), pp 869-884. https://doi.org/10.1080/14756366.2021.1900162. [Impact factor 4.673].
  23. Nizar A. Al-Shar’i and Sondos Musleh. ‘’CHK1 Kinase Inhibition: Identification of Allosteric Hits Using MD Simulations, Pharmacophore Modeling, Docking and MM-PBSA Calculations’’. Molecular Diversity. (2021), volume 26 (2), pp 903-921.https://doi.org/10.1007/s11030-021-10202-w. [Impact factor 2.013].
  24. Nizar A. Al-Shar’i. ‘’Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations. Journal of Biomolecular Structure and Dynamics. (2021), volume 39 (17), pp 6689-6704. https://doi.org/10.1080/07391102.2020.1800514. [Impact factor 3.31].
  25. Nizar A. Al-Shar’i, Qosay A. Al-Balas, Mohammad A. Hassan, Tamam El-Elimat, Ghazi A. Al Jabal, and Ammar M. Almaaytah. “Ellagic Acid: A Potent Glyoxalase-I Inhibitor with a Unique Scaffold”. Acta Pharmaceutica. (2021), volume 71, pp 115-130. https://doi.org/10.2478/acph-2021-0005. [Impact factor 1.41].
  26. Nizar A. Al-Shar’i and Sondos Musleh. “Identification of CHK1 Kinase Inhibitors Using Structure Based Pharmacophore Modelling and Molecular Docking”. Indian Journal of Pharmaceutical Sciences. (2020), volume 82 (3), pp 472-482. https://doi.org/10.36468/pharmaceutical-sciences.670. [Impact factor 0.634].
  27. ‑Balas, Nizar A. Al-Shar’i, Amanda Bryant-Friedrich, Mel F. Bedi. ‘’Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents’’. Bioorganic and Medicinal Chemistry. (2020), volume 28 (16), p 115608.  https://doi.org/10.1016/j.bmc.2020.115608. [Impact factor 2.802].
  28. ‑Balas. ‘’Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking’’. Molecules. (2020), volume25 (12), p 2871. https://doi.org/10.3390/molecules25122871. [Impact factor 3.06].
  29. Nizar A. Al-Shar’i, Mohammad A. Hassan, Hadil M. Al-Barqi, Qosay A. Al-Balas, and Tamam El-Elimat. ‘’Discovery of Novel Glyoxalase-I Inhibitors Using Computational Fragment-Based Drug Design Approach’’. Jordan Journal of Pharmaceutical Sciences. (2020), volume 13 (2), pp 225-245. [Scopus Q3, SJR 0.15].
  30. Nizar A. Al-Shar’i, Enas K. Al-Rousan, Lara I. Fakhouri, Qosay A. Al-Balas, and Mohammad A. Hassan. “Discovery of a Nanomolar Glyoxalase-I Inhibitor Using Integrated Ligand-Based Pharmacophore Modelling and Molecular Docking”. Medicinal Chemistry research. (2020), volume 29, pp 356-376. https://doi.org/10.1007/s00044-019-02486-3. [Impact factor 1.72].
  31. Nizar A. Al-Shar’i, Qosay A. Al-Balas, Rand A. Al-Waqfi, Mohammad A. Hassan, Amer E. Alkhalifa, Nehad M. Ayoub. “Discovery of a Nanomolar Inhibitor of the Human Glyoxalase-I Enzyme Using Structure-Based Poly-pharmacophore Modelling and Molecular Docking”. Journal of Computer Aided Molecular Design. (2019), volume 33, (9), pp 799-815. https://doi.org/10.1007/s10822-019-00226-8. [Impact factor 3.25].
  32. Soraya M. Alnabulsi, Enas S. Al-Horani, Nizar A. Al-Shar’i, and Tamam El-Elimat. ‘Amino-carboxamide benzothiazoles as potential LSD1 hit inhibitors. Part I: Computational fragment-based drug design’’. Journal of Molecular Graphics and Modelling. (2019), volume 93, December 2019, p 107440. https://doi.org/10.1016/j.jmgm.2019.107440. [Impact factor 1.86].
  33. Soraya Alnabulsi and Nizar A. Al-Shar’i. “Hit Identification of an SMYD3 Enzyme Inhibitor Using Structure-Based Pharmacophore Modelling”. Future Medicinal Chemistry. (2019), volume 11 (10), pp 1107-1117. https://doi.org/10.4155/fmc-2018-0462. [Impact factor 3.97].
  34. Qosay Ali Al-Balas, Nizar Al-Shar’i, Mohammad A. Hassan, Katreen banisalman. “Design, Synthesis and Biological Evaluation of potential Novel Zinc Binders Targeting Human Glyoxalase-I; A Validated Target for Cancer Treatment”. Jordan Journal of Pharmaceutical Sciences. (2018), volume 11 (1), pp 25-37. [RG journal impact factor 0.23].
  35. Qosay A. Al-Balas, Mohammad A. Hassan, Nizar A. Al-Shar’i, Tamam El-Elimat, Ammar M. Almaaytah. “Computational and experimental exploration of the structure-activity relationships of flavonoids as potent glyoxalase-I inhibitors”. Drug Development Research. (2018) March, volume 79 (2), pp 58-69. https://doi.org/10.1002/ddr.21421. [Impact factor 1.91].
  36. Nizar A. Al-Shar’i, Rana Obaidat. “Experimental and Computational Comparative Study of the Supercritical Fluid Technology (SFT) and Kneading Method in Preparing β-Cyclodextrin Complexes with Two Essential Oils (Linalool and Carvacrol)”. AAPS PharmSciTech. (2018) April, volume 19 (3), pp 1037-1047. https://doi.org/10.1208/s12249-017-0915-x. [Impact factor 2.45].
  37. Rana Obaidat, Nizar Al-Shar’i, Bassam Tashtoush, and Tamara Athamneh. “Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches”, Pharmaceutical Development and Technology, (2018), volume 23:10, P. 986-997.https://doi.org/10.1080/10837450.2016.1245319. [Impact factor 1.86].
  38. Qosay A. Al-Balas, Mohammad A. Hassan, Ghazi A. Al Jabal, Nizar Al-Shar’i, Ammar M. Almaaytah, Tamam M. Elimat. “Novel Thiazole Carboxylic Acid Derivatives Possessing a “Zinc Binding Feature” as Potential Human Glyoxalase-I Inhibitors”, Letters in Drug Design and Discovery. (2017), volume 14 (11), pp 1324-1334. https://doi.org/10.2174/1570180814666170306120954. [Impact factor 1.17].
  39. Ammar Almaaytah, Ya’u Ajingi, Ahmad Abualhaijaa, Shadi Tarazi, Nizar Al-shar’i, and Qosay Al-Balas.  “Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides”, Infection and Drug Resistance. (2017), volume 10, pp 1-17. https://doi.org/10.2147/IDR.S118877. [Impact factor 3.78].
  40. Qosay A Al-Balas, Mohammad A Hassan, Nizar A Al-Shar’i, Nizar M Mhaidat, Ammar M Almaaytah, Fatima M Al-Mahasneh, Israa H Isawi. “Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents”, Drug Design, Development and Therapy. (2016), volume 10, pp 2623-2629. https://doi.org/10.2147/DDDT.S110997. [Impact factor 2.82].
  41. Nizar A. Al-Shar’i and Soraya M. Alnabulsi. “Explaining the autoinhibition of the SMYD enzyme family: a theoretical study”, Journal of Molecular Graphics and Modelling. (2016), volume 68, pp 147-157. https://doi.org/ 10.1016/j.jmgm.2016.07.001. [Impact factor 1.75].
  42. Ammar Almaaytah, Adan Alnaamneh, Ahmad Abualhaijaa, Nizar Al-shar’i, and Qosay Al-Balas. “In Vitro Synergistic Activities of the Hybrid Antimicrobial Peptide MelitAP-27 in Combination with Conventional Antibiotics Against Planktonic and Biofilm Forming Bacteria”, International Journal of Peptide Research and Therapeutics. (2016) December, volume 22 (4), pp 497-504. https://doi.org/10.1007/s10989-016-9530-z. [Impact factor 0.91].
  43. Nizar Al-Shar’i, Mohammad Hassan, Qosay Al-Balas, and Ammar Almaaytah. “Identification of Possible Glyoxalase II Inhibitors as Anticancer Agents by a Customized 3D Structure-Based Pharmacophore Model”. Jordan Journal of Pharmaceutical Sciences. (2015), volume 8 (2), pp 83-103. [RG journal impact factor 0.23].
  44. Ammar Almaaytah, Shadi Tarazi, Mohammad Al-Fandi, Ahmad Abuilhaija, Nizar Al-shar’i, Qosay Al-Balas, and Aymen Abu-Awad. “The Design and Functional Characterization of the Antimicrobial and Antibiofilm Activities of BMAP27-Melittin, a Rationally Designed Hybrid Peptide”, International Journal of Peptide Research and Therapeutics. (2014), volume 21 (2), pp 165-177. https://doi.org/10.1007/s10989-014-9444-6. [Impact factor 0.91].
  45. Ammar Almaaytah, Shadi Tarazi, Ahmad Abu-Alhaijaa, Yara Altall, Nizar Al-shar’i, Khaldon Bodoor, and Qosay Al-Balas. “Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1”, Pharmaceuticals. (2014), volume 7 (5), pp 502-516. https://doi.org/10.3390/ph7050502. [Citescore 3.80].
  46. Al-Shar’i, N, Al-Jaidi, B, Johnston, BF, Robertson, MN, Mackay, SP and Clark, RL, “The drug discovery portal library: a unique resource to enhance drug discovery in academia”, Journal of Pharmacy and Pharmacology. (2010), volume 62 (10), special issue, p 1382-1382. [Impact factor 1.92].
  47. Amjad M. Qandil, Mohammad A. Hassan, Nizar A. Al-Shar’i. “Synthesis and Anticandidal Activity of Azole-Containing Sulfonamides”, Archiv der Pharmazie. (2007), volume 341 (2), pp 99-112. https://doi.org/10.1002/ardp.200700125. [Impact factor 1.43].

Review articles:

  1. Rajashri Bezbaruah, Pobitra Borah, Bibhuti Bhushan Kakoti, Nizar Al-Shar’i, Balakumar Chandrasekaran, Da’san Mahmoud Mousa Jaradat, Munir Al-Zeer and Saeid Abu-Romman. “Developmental landscape of potential vaccine candidates based on viral vector for prophylaxis of COVID-19”. Review, Frontiers in Molecular Biosciences – Molecular Diagnostics and Therapeutics. (2021), volume 8, article 635337. https://doi.org/10.3389/fmolb.2021.63533700. [Impact factor 4.19].
  2. Pobitra Borah, Pran Kishore Deb, Nizar Al-Shar’i, Lina Dahabiyeh, Katharigatta Narayanaswamy Venugopala, Vinayak Singh, Snawar Hussain, Shinu Pottathil, Satyendra Deka, Balakumar Chandrasekaran and Da’san Mahmoud Mousa Jaradat. “Perspectives on RNA vaccine candidates for COVID-19“. Frontiers in Molecular Biosciences – Molecular Diagnostics and Therapeutics. (2021), volume 8, article 635245. https://doi.org/10.3389/fmolb.2021.635245. [Impact factor 4.19].
  3. Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, Manoj Goyal, Monika Bansal, Snawar Hussain, Shinu Pottathil, Katharigatta Narayanaswamy Venugopala, Nizar A Al-Shar’i, Satyendra Deka and Vinayak Singh. “Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: Navigating the uncharted”. Frontiers in Molecular Biosciences – Molecular Diagnostics and Therapeutics. (2021), volume 8, article 627723. https://doi.org/10.3389/fmolb.2021.627723. [Impact factor 4.19].
  4. Pobitra Borah, Pran Kishore Deb, Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Vinayak Singh, Satyendra Deka, Amavya Srivastava, Vinod Tiwari, Raghu Prasad Mailavaram. “Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host-Directed Therapies”. Current Topics in Medicinal Chemistry. (2021), volume 21 (6), pp 547 – 570. https://doi.org/10.2174/1568026621999201211200447. [Impact factor 3.22].
  5. Nizar A. Al-Shar’i and Qosay A. Al-Balas. “Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends”. Current Pharmaceutical Design. (2019), volume 25 (7), pp 783-816. https://doi.org/10.2174/1381612825666190304123414. [Impact factor 2.76].
  6. Qosay A. Al-Balas, Mohammad A. Hassan, Nizar A. Al-Shar’i, Ghazi A. Al Jabal and Ammar M. Almaaytah. “Recent Advances in Glyoxalase-I Inhibition”. Mini-Reviews in Medicinal Chemistry. (2019) January, volume 19 (4), pp 281-291. https://doi.org/10.2174/1389557518666181009141231. [Impact factor 2.65]

Book chapters:

  1. Bhakti Pawar, Santosh Kumar Behera, Muktika Tekade, Nizar Al-Shar’i, Rakesh Kumar Tekade. Chapter 9, “Computer-aided technologies in drug discovery and toxicity prediction”. Editor: Rakesh Tekade. In Advances in Pharmaceutical Product Development and Research. Essentials of Pharmatoxicology in Drug Research, Volume 1, Academic Press, Volume 1, (2023), Pages 239-254, ISBN 9780443158407, https://doi.org/10.1016/B978-0-443-15840-7.00004-X.
  2. Pobitra Borah, Sangeeta Hazarika, Dikshya Sharma, Katharigatta N. Venugopala, Deepak Chopra, Nizar A. Al-Shar’i, Siva Hemalatha, Ashok K. Shakya, Pratap Chandra Acharya, Pran Kishore Deb. Chapter 9, “Systemic and topical antifungal drugs”. Editor(s): Pratap Chandra Acharya, Michio Kurosu. In Medicinal Chemistry of Chemotherapeutic Agents. Academic Press, (2023), Pages 285-315, ISBN 9780323905756, https://doi.org/10.1016/B978-0-323-90575-6.00002-8.
  3. Pobitra Borah, Sangeeta Hazarika, Ashna Chettri, Dikshya Sharma, Satyendra Deka, Katharigatta N Venugopala, Pottathil Shinu, Nizar A Al-Shar’i, Sanaa K Bardaweel, Pran Kishore Deb. Chapter 61, “Heterocyclic compounds as antimicrobial agents”. Editors: Debasis Bagchi, Amitava Das, Bernard William Downs. In Viral, Parasitic, Bacterial, and Fungal Infections. Academic Press, (2023), Pages 781-804, ISBN 9780323857307, https://doi.org/10.1016/B978-0-323-85730-7.00068-0.
  4. Sarah Falah Kokaz, Pran Kishore Deb, Pobitra Borah, Ratnali Bania, Katharigatta N. Venugopala, Anroop B. Nair, Vinayak Singh, Nizar A. Al-Shar’i, Rakesh Kumar Tekade. Chapter 8, “Dendrimers: Properties and Applications in Biomedical Field”. Editors: Sougata Jana, Subrata Jana. In Nanoengineering of Biomaterials. Wiley Online Library, (2022), https://doi.org/10.1002/9783527832095.ch25.
  5. Ratnali Bania, Pobitra Borah, Satyendra Deka, Lina A. Dahabiyeh, Vinayak Singh, Nizar A. Al-Shar’i, Anroop B. Nair, Manoj Goyal, Katharigatta N. Venugopala, Rakesh Kumar Tekade, Pran Kishore Deb. Chapter 22, “Current strategies in targeted anticancer drug delivery systems to brain”. Editors: Kamal Dua, Meenu Mehta, Terezinha de Jesus Andreoli Pinto, Lisa G. Pont, Kylie A. Williams, Michael J. Rathbone. Advanced Drug Delivery Systems in the Management of Cancer. Academic Press, (2021), pp 267-280, ISBN 9780323855037. https://doi.org/10.1016/B978-0-323-85503-7.00038-9.